Akkari L, Bowman RL, Tessier J, Klemm F, Handgraaf SM, de Groot M, Quail DF, Tillard L, Gadiot J, Huse JT, Brandsma D, Westerga J, Watts C, Joyce JA (2020) ‘Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance’, Sci Transl Med, 12

Cancer Genome Atlas Research, Network JN, Weinstein EA, Collisson GB, Mills KR, Shaw BA, Ozenberger K, Ellrott I, Shmulevich C, Sander and J. M. Stuart. 2013. ‘The Cancer Genome Atlas Pan-Cancer analysis project’, Nat Genet, 45: 1113–1120

Chen Z, Hambardzumyan D (2018) Immune Microenvironment in Glioblastoma subtypes. Front Immunol 9:1004

Article  PubMed  PubMed Central  Google Scholar 

Chen DS, Mellman I (2013) ‘Oncology meets immunology: the cancer-immunity cycle’, Immunity, 39: 1–10

Chen Y, Huo R, Kang W, Liu Y, Zhao Z, Fu W, Ma R, Zhang X, Tang J, Zhu Z, Lyu Q, Huang Y, Yan M, Jiang B, Chai R, Bao Z, Hu Z, Wang W, Jiang T, Cao Y, Wang J (2023) Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma. Cell Rep Med 4:101177

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colquhoun A (2017) Cell biology-metabolic crosstalk in glioma. Int J Biochem Cell Biol 89:171–181

Article  CAS  PubMed  Google Scholar 

Dang W, Xiao J, Ma Q, Miao J, Cao M, Chen L, Shi Y, Yao X, Yu S, Liu X, Cui Y, Zhang X, Bian X (2021) Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia. Brain Tumor Pathol 38:189–200

Article  CAS  PubMed  Google Scholar 

Daubon T, Hemadou A, Romero Garmendia I, Saleh M (2020) Glioblastoma Immune Landscape and the potential of New immunotherapies. Front Immunol 11:585616

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong L, Ji L, Xu D, Wang J, Zou J (2021) TGF-beta links glycolysis and immunosuppression in glioblastoma. Histol Histopathol 36:1111–1124

CAS  PubMed  Google Scholar 

Hanahan D (2022) Hallmarks of Cancer: New dimensions. Cancer Discov 12:31–46

Article  CAS  PubMed  Google Scholar 

Hasan MN, Luo L, Ding D, Song S, Bhuiyan MIH, Liu R, Foley LM, Guan X, Kohanbash G, Hitchens TK, Castro MG, Zhang Z, Sun D (2021) ‘Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells’, Theranostics, 11: 1295 – 309

Ishikawa E, Miyazaki T, Takano S, Akutsu H (2021) Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy. Brain Tumor Pathol 38:149–155

Article  CAS  PubMed  Google Scholar 

Jackson CM, Choi J, Lim M (2019) Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat Immunol 20:1100–1109

Article  CAS  PubMed  Google Scholar 

Karimian-Jazi K, Munch P, Alexander A, Fischer M, Pfleiderer K, Piechutta M, Karreman MA, Solecki GM, Berghoff AS, Friedrich M, Deumelandt K, Kurz FT, Wick W, Heiland S, Bendszus M, Winkler F, Platten M and M. O. Breckwoldt. 2020. ‘Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM)’, Theranostics, 10: 1873–1883

Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, Ito D, Fujii R, Watanabe S, Sai A, Fukuoka S, Sugiyama E, Watanabe G, Owari T, Nishinakamura H, Sugiyama D, Maeda Y, Kawazoe A, Yukami H, Chida K, Ohara Y, Yoshida T, Shinno Y, Takeyasu Y, Shirasawa M, Nakama K, Aokage K, Suzuki J, Ishii G, Kuwata T, Sakamoto N, Kawazu M, Ueno T, Mori T, Yamazaki N, Tsuboi M, Yatabe Y, Kinoshita T, Doi T, Shitara K, Mano H, Nishikawa H (2022) ‘Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments’, Cancer Cell, 40: 201 – 18 e9.

Lee AH, Sun L, Mochizuki AY, Reynoso JG, Orpilla J, Chow F, Kienzler JC, Everson RG, Nathanson DA, Bensinger SJ, Liau LM, Cloughesy T, Hugo W, Prins RM (2021) Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive Tumor associated macrophages in recurrent glioblastoma. Nat Commun 12:6938

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Gao J, Zhuang X, Zhao C, Hou X, Xing X, Chen C, Liu Q, Liu S, Luo Y (2019) Cyclin G2 inhibits the Warburg Effect and Tumour Progression by suppressing LDHA phosphorylation in Glioma. Int J Biol Sci 15:544–555

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Kaneda MM, Ma J, Li M, Shepard RM, Patel K, Koga T, Sarver A, Furnari F, Xu B, Dhawan S, Ning J, Zhu H, Wu A, You G, Jiang T, Venteicher AS, Rich JN, Glass CK, Varner JA, Chen CC (2021) ‘PI3Kgamma inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response’, Proc Natl Acad Sci U S A, 118

Lim M, Weller M, Idbaih A, Steinbach J, Finocchiaro G, Raval RR, Ansstas G, Baehring J, Taylor JW, Honnorat J, Petrecca K, De Vos F, Wick A, Sumrall A, Sahebjam S, Mellinghoff IK, Kinoshita M, Roberts M, Slepetis R, Warad D, Leung D, Lee M, Reardon DA, Omuro A (2022) ‘Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter’, Neuro Oncol

Poff A, Koutnik AP, Egan KM, Sahebjam S, D’Agostino D, Kumar NB (2019) Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin Cancer Biol 56:135–148

Article  CAS  PubMed  Google Scholar 

Pudova EA, Kudryavtseva AV, Fedorova MS, Zaretsky AR, Shcherbo DS, Lukyanova EN, Popov AY, Sadritdinova AF, Abramov IS, Kharitonov SL, Krasnov GS, Klimina KM, Koroban NV, Volchenko NN, Nyushko KM, Melnikova NV, Chernichenko MA, Sidorov DV, Alekseev BY, Kiseleva MV, Kaprin AD, Dmitriev AA, Snezhkina AV (2018) HK3 overexpression associated with epithelial-mesenchymal transition in Colorectal cancer. BMC Genomics 19:113

Article  PubMed  PubMed Central  Google Scholar 

Rabold K, Netea MG, Adema GJ, Netea-Maier RT (2017) Cellular metabolism of tumor-associated macrophages - functional impact and consequences. FEBS Lett 591:3022–3041

Article  CAS  PubMed  Google Scholar 

Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bahr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M (2020) Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 Randomized Clinical Trial. JAMA Oncol 6:1003–1010

Article  PubMed  Google Scholar 

Spill F, Reynolds DS, Kamm RD, Zaman MH (2016) Impact of the physical microenvironment on Tumor progression and Metastasis. Curr Opin Biotechnol 40:41–48

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuo Z, Zheng X, Zong Y, Li J, Zou C, Lv Y, Liu J (2020) HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell Lung cancer. Clin Transl Med 10:319–330

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Xu T, Huang Q, Jin W, Chen J (2020) Immunotherapy for malignant glioma: current status and future directions. Trends Pharmacol Sci 41:123–138

Article  CAS  PubMed  Google Scholar 

Warburg O (1956) On the origin of cancer cells. Science 123:309–314

Article  CAS  PubMed  Google Scholar 

Wu X, Qian S, Zhang J, Feng J, Luo K, Sun L, Zhao L, Ran Y, Sun L, Wang J, Xu F (2021) Lipopolysaccharide promotes Metastasis via acceleration of glycolysis by the nuclear factor-kappaB/snail/hexokinase3 signaling axis in Colorectal cancer. Cancer Metab 9:23

Article  PubMed  PubMed Central  Google Scholar 

Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, Wu M, Wu F, Zhou F, Du Y, Chai RC, Zhang W, Qiu X, Liu Q, Wang Z, Li J, Li K, Chen A, Jiang Y, Xiao X, Zou H, Srivastava R, Zhang T, Cai Y, Liang Y, Huang B, Zhang R, Lin F, Hu L, Wang X, Qian X, Lv S, Hu B, Zheng S, Hu Z, Shen H, You Y, Verhaak RGW, Jiang T, Wang Q (2022) ‘Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma’, Cancer Discov, 12: 2820-37

Wu F, Yin YY, Fan WH, Zhai Y, Yu MC, Wang D, Pan CQ, Zhao Z, Li GZ, Zhang W (2023) ‘Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes’, EBioMedicine, 87: 104410

Xu S, Tang L, Li X, Fan F, Liu Z (2020) Immunotherapy for glioma: current management and future application. Cancer Lett 476:1–12

Article  CAS  PubMed  Google Scholar 

Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, Yuan H, Cheng P, Li F, Long Z, Yan M, Zhao T, Xiao Y, Li X 2018. ‘TIP: A Web Server for Resolving Tumor Immunophenotype Profiling’, Cancer Res, 78: 6575–6580

Ye L, Gu L, Zheng Z, Zhang X, Xing H, Guo X, Chen W, Wang Y, Wang Y, Liang T, Wang H, Li Y, Jin S, Shi Y, Liu D, Yang T, Liu Q, Deng C, Wang Y, Ma W (2023) An online survival predictor in glioma patients using machine learning based on WHO CNS5 data. Front Neurol 14:1179761

Article  PubMed  PubMed Central  Google Scholar 

Yuan J, Peng G, Xiao G, Yang Z, Huang J, Liu Q, Yang Z, Liu D (2020) Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis. J Cancer 11:4047–4058

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, Liu R, Gao H, Tao B, Li W, Li G, Liang J, Yang W (2018) Macrophage-Associated PGK1 phosphorylation promotes aerobic glycolysis and Tumorigenesis. Mol Cell 71:201–215 e7

Article  CAS  PubMed  Google Scholar 

Zhang X, Chen L, Dang WQ, Cao MF, Xiao JF, Lv SQ, Jiang WJ, Yao XH, Lu HM, Miao JY, Wang Y, Yu SC, Ping YF, Liu XD, Cui YH, Zhang X, Bian XW (2020) CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling. Lab Invest 100:619–629

Article  CAS  PubMed  Google Scholar 

Zhang N, Zhang H, Wang Z, Dai Z, Zhang X, Cheng Q, Liu Z (2021) Immune infiltrating cells-derived risk signature based on large-scale analysis defines Immune Landscape and predicts immunotherapy responses in Glioma Tumor Microenvironment. Front Immunol 12:691811

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao B, Wang Y, Wang Y, Dai C, Wang Y, Ma W (2021a) Investigation of genetic determinants of Glioma Immune phenotype by Integrative Immunogenomic Scale Analysis. Front Immunol 12:557994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Huang H, Jia CH, Fan K, Xie T, Zhu ZY, Xie ML (2021b) Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1alpha-mediated glycolysis. Med Oncol 38:131

Article  CAS  PubMed  Google Scholar 

Zhao Z, Wang Z, Wu Y, Liao D, Zhao B (2022) Comprehensive analysis of TAMs marker genes in glioma for predicting prognosis and immunotherapy response. Mol Immunol 144:78–95

Article  CAS  PubMed  Google Scholar 

Zhou W, Wahl DR (2019) ‘Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance’, Cancers (Basel), 11

Zhou F, Shi Q, Fan X, Yu R, Wu Z, Wang B, Tian W, Yu T, Pan M, You Y, Wang Y (2022) Diverse macrophages constituted the Glioma Microenvironment and Influenced by PTEN Status. Front Immunol 13:841404

Article  CAS  PubMed  PubMed Central  Google Scholar